Skip to content

To Study Effect of Rasnadwadash Kashay With Erand Tail in Management of Amavata.

Open Label Clinical Trial of Rasnadwadash Kashay with Erand Tail in Amavata( Rheumatoid Arthritis) With Special Reference to C-Reactive Protein. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081513
Enrollment
30
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified Health Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Priyanka Rushi Taram
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with age group of 20 to 60 years of age respective of gender.2. Patients having fulfilling assessment criteria of Amavata.3.ARA(American Rheumatoid Arthritis ) Score more than or equal to six.4.Patients with high CRP(Greater than 6 mg per dl). 5.Patients who are willing to participate in the study after written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with age group less than 20 and more than 60 years.2.Patients having Rheumatic fever, Infective Arthritis, pulmonary tuberculosis.3.Patients having SLE, Auto-immune Diseases, CTDs.4.Patients with co-morbidities such as uncontrolled diabetes mellitus, chronic kidney disease.5.Pregnant women and lactating women.

Design outcomes

Primary

MeasureTime frame
To study the effect of Rasnadwadash Kashay with erand tailin Amavata(Rheumatoid Arthritis)with special reference to C-Reactive protein.Timepoint: To study the effect of Rasnadwadash Kashay with erand tailin Amavata(Rheumatoid Arthritis)with special reference to C-Reactive protein.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactPranali Bhende

Government Ayurved College and Hospital Sakkardara Square Nagpur

vdpranali@gmail.com9867351304

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026